6,521 Shares in CVS Health Corporation $CVS Acquired by Syverson Strege & Co

01 Nov 2025, 07:18 by Teresa Graham · The Cerbat Gem

Syverson Strege & Co purchased a new stake in CVS Health Corporation (NYSE:CVS – Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 6,521 shares of the pharmacy operator’s stock, valued at approximately $450,000.

A number of other hedge funds also recently made changes to their positions in the stock. Avion Wealth lifted its position in CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares in the last quarter. Harbor Asset Planning Inc. acquired a new position in shares of CVS Health during the 2nd quarter valued at $30,000. Bell Investment Advisors Inc lifted its stake in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 248 shares in the last quarter. Roxbury Financial LLC lifted its stake in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares in the last quarter. Finally, ORG Partners LLC lifted its stake in shares of CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 377 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Activity at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 1.22% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on CVS. The Goldman Sachs Group began coverage on CVS Health in a research report on Tuesday, October 14th. They set a “buy” rating and a $91.00 price target on the stock. Zacks Research cut shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Cantor Fitzgerald boosted their price objective on shares of CVS Health from $78.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Truist Financial reiterated a “buy” rating and issued a $95.00 price target (up previously from $92.00) on shares of CVS Health in a research note on Thursday. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $86.33.

View Our Latest Report on CVS

CVS Health Stock Performance

CVS stock opened at $78.13 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83. The firm has a market cap of $99.09 billion, a P/E ratio of 205.61, a P/E/G ratio of 0.87 and a beta of 0.60. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $85.15. The stock’s 50 day simple moving average is $76.49 and its 200 day simple moving average is $69.04.

CVS Health (NYSE:CVS – Get Free Report) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the company earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. CVS Health’s dividend payout ratio is currently 74.30%.

CVS Health Profile

(Free Report)